0001415889-23-013038.txt : 20230906 0001415889-23-013038.hdr.sgml : 20230906 20230906190349 ACCESSION NUMBER: 0001415889-23-013038 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230901 FILED AS OF DATE: 20230906 DATE AS OF CHANGE: 20230906 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Paolini John F. CENTRAL INDEX KEY: 0001741533 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38492 FILM NUMBER: 231240611 MAIL ADDRESS: STREET 1: C/O KINIKSA PHARMACEUTICALS, LTD. STREET 2: CLARENDON HOUSE, 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 FORMER NAME: FORMER CONFORMED NAME: Paolini John DATE OF NAME CHANGE: 20180522 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd. CENTRAL INDEX KEY: 0001730430 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 BUSINESS PHONE: 7814399100 MAIL ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 4 1 form4-09062023_110943.xml X0508 4 2023-09-01 0001730430 Kiniksa Pharmaceuticals, Ltd. KNSA 0001741533 Paolini John F. C/O KINIKSA PHARMACEUTICALS, LTD. CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM 11 BERMUDA false true false false CHIEF MEDICAL OFFICER 1 Class A Common Share 2023-09-01 4 M 0 2498 A 44408 D Class A Common Share 2023-09-01 4 F 0 734 17.76 D 43674 D Class A Common Share 2023-09-02 4 M 0 1725 A 45399 D Class A Common Share 2023-09-02 4 F 0 507 17.76 D 44892 D Class A Common Share 2023-09-05 4 M 0 400 1.86 A 45292 D Class A Common Share 2023-09-05 4 S 0 400 17.53 D 44892 D Restricted Share Unit 2023-09-01 4 M 0 2498 0 D Class A Common Share 2498 7492 D Restricted Share Unit 2023-09-01 4 A 0 6496 0 A Class A Common Share 6496 6496 D Share Option 17.76 2023-09-01 4 A 0 38974 0 A 2033-08-31 Class A Common Share 38974 38974 D Restricted Share Unit 2023-09-02 4 M 0 1725 0 D Class A Common Share 1725 3450 D Share Option 1.86 2023-09-05 4 M 0 400 0 D 2026-09-13 Class A Common Share 400 139817 D Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $17.50 to $17.56. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 1, 2022. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 1, 2023. The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2023. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 2, 2021. The option is fully vested and exercisable. /s/ Madelyn Zeylikman, Attorney-in-Fact 2023-09-06